Diabetes · Florida
Diabetes studies in Florida
98 studies have at least one recruiting site in Florida. Diabetes research covers type 1 and type 2 diabetes, prediabetes and related complications, testing medicines, devices such as glucose monitors and insulin pumps, and lifestyle programs.
98 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL Behring
- Location
- Boca Raton, FL + 147 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ascletis Pharma (China) Co., Limited
- Location
- Melbourne, FL + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Melbourne, FL + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
Biodynamik, Inc
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 22+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Fort Myers, FL + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Hollywood, FL + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Lakewood-Amedex Inc
- Location
- Doral, FL + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
AstraZeneca
- Location
- Miami Lakes, FL + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Miami, FL + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- Clearwater, FL + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Kodiak Sciences Inc
- Location
- St. Petersburg, FL + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Mannkind Corporation
- Location
- Gainsville, FL + 9 other US sites
- Eligibility basics
- Ages 6–17
- Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Reprise Biomedical, Inc.
- Location
- Coral Gables, FL + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Jacksonville, FL + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
AstraZeneca
- Location
- Ocoee, FL
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Walden Biosciences
- Location
- Tamarac, FL + 8 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Insulet Corporation
- Location
- West Palm Beach, FL + 25 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Gateway Institute for Brain Research
- Location
- Davie, FL + 3 other US sites
- Eligibility basics
- Ages 30+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Boca Raton, FL + 69 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Eli Lilly and Company
- Location
- Bradenton, FL + 35 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Neurologic Stem Cell Treatment Study
MD Stem Cells
- Location
- Coral Springs, FL + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Pharming Technologies B.V.
- Location
- Miami, FL + 10 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
RxFunction Inc.
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 60+
- RecruitingPhase 1
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
Hua Medicine Limited
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.
Questions
Will I have to stop my diabetes medicine?
Some studies change or pause medicines under close supervision; many add a study treatment on top of your current care. Never change medicines on your own; the study team and your doctor decide this together.